MM

Melinda McGrath

Australian Clinical Labs Limited | Chief Executive Officer, Executive Director
Ms McGrath has been the Chief Executive Officer and Executive Director of ACL's predecessor corporate vehicle, Clinical Laboratories Pty Ltd since 2015. Melinda has led the organization's restructure and transformation, building ACL's scale and operational performance improvement over the past seven years, overseeing the integration of Healthscope's Australian pathology business, St John of God Health Care's pathology business, Perth Pathology, SunDoctors and MedLab Pathology. She has also driven the establishment of one performance-oriented culture across the organization, via one unified integrated pathology system.

Company and Roles

Company
Title
Tenure
Since
ACL
Australian Clinical Labs Limited
  • Chief Executive Officer
  • Executive Director
3yrs, 6mthDec 2020

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ACL
Australian Clinical Labs Limited
30/06/232,173,867749,464N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ACL
Australian Clinical Labs Limited
20/12/23
Issued
395,490$2.280$901,717Issue of securities
ACL
Australian Clinical Labs Limited
13/03/23
Issued
238,092$3.780$899,987Issue of securities
ACL
Australian Clinical Labs Limited
15/09/22
Issued
65,658$4.270$280,359Dividend Reinvestment Plan (DRP)
ACL
Australian Clinical Labs Limited
21/04/22
Issued
50,359$5.060$254,816Dividend Reinvestment Plan (DRP)
ACL
Australian Clinical Labs Limited
21/04/22
Issued
15,841$5.060$80,155Dividend Reinvestment Plan (DRP)